Mike: I remember the nurse saying that she looked great when she was born. And she was, she was - she was exactly what you'd expect a baby to look like, but just smaller, like everything was there in proportion, nothing — Emily: Perfectly formed, yeah. Mike: Like I mean, it wasn't like a - like a fetus, you know, they're slightly still developing. Like she, she was ready. All she was going to do from there was get bigger.
BBC NEWS | Health | 'Cancer risk' of miscarriage drug
It has already been linked to a higher risk of reproductive system cancers. UK experts said the Boston University study did find DES increased breast cancer risk, but said exposure did not mean women would develop the disease. Daughters of mothers who took the drug DES during their pregnancies may have a higher risk of breast cancer as they get older, but this does not mean that they will definitely develop the disease Ed Yong, Cancer Research UK DES, a synthetic oestrogen, was developed in as a treatment for women with low levels of natural oestrogen during pregnancy, who doctors believed were at an increased risk of abortions and premature births. However, in , a clinical study found DES did nothing to reduce the risk of miscarriage.